It is moving slowly but the fact that the GB clinical trials have been registered with the FDA shows that there are people at RCPI with a strategy. Having said that, the company's goal to be a "drug" probably hurt a lot of people who wanted it as a nutraceutical. I am not smart enough to know if there some path forward where they could be both.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.